Schrodinger
SDGR
22.93
-3.41
-12.95%
Schrodinger
US · SDGR
#2667 by market cap
Listed 2020
22.93
-3.41
-12.95%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Company notice
Schrodinger | 4: Statement of changes in beneficial ownership of securities-Officer Tran YvonneSEC · 2026/11/11
-
Morgan Stanley Maintains Schrodinger(SDGR.US) With Hold Rating, Raises Target Price to $29Market Newswire · 2026/11/6
-
Rating change
Schrodinger Price Target Raised to $21.00/Share From $19.00 by UBSDow Jones · 2026/10/20
-
Company notice
Schrodinger | 4: Statement of changes in beneficial ownership of securities-Officer Abel Robert LorneSEC · 2026/11/13
-
UBS Maintains Schrodinger(SDGR.US) With Hold Rating, Raises Target Price to $30Market Newswire · 2026/11/6
-
BofA Securities Initiates Schrodinger(SDGR.US) With Buy RatingMarket Newswire · 2026/11/11
-
Rating change
Schrodinger Price Target Raised to $31.00/Share From $20.00 by TD CowenDow Jones · 2026/10/14
-
Rating change
TD Cowen Maintains Schrodinger(SDGR.US) With Buy Rating, Raises Target Price to $31Market Newswire · 2026/10/13
-
TD Cowen Maintains Schrodinger(SDGR.US) With Buy Rating, Raises Target Price to $36Market Newswire · 2026/11/5
-
Rating change
BMO Capital Maintains Schrodinger(SDGR.US) With Buy Rating, Raises Target Price to $30Market Newswire · 2026/10/12
-
Rating change
TD Cowen Maintains Buy on Schrodinger, Raises Price Target to $31Benzinga · 2026/10/14
-
Company notice
Schrodinger | 4: Statement of changes in beneficial ownership of securities-Officer Davie Paul JonathanSEC · 2026/11/13
-
Rating change
UBS Maintains Neutral on Schrodinger, Raises Price Target to $21Benzinga · 2026/10/20
-
Rating change
BMO Capital Maintains Schrodinger(SDGR.US) With Buy Rating, Raises Target Price to $35Market Newswire · 2026/11/5
-
Morgan Stanley Initiates Schrodinger(SDGR.US) With Hold Rating, Announces Target Price $29Market Newswire · 2026/11/5
-
Rating change
Schrodinger Is Maintained at Neutral by UBSDow Jones · 2026/10/20
-
Rating change
KeyBanc Maintains Schrodinger(SDGR.US) With Buy Rating, Raises Target Price to $32Market Newswire · 2026/10/16
-
Rating change
BMO Capital Maintains Outperform on Schrodinger, Raises Price Target to $30Benzinga · 2026/10/13
-
Company notice
Schrodinger | 3: Initial statement of beneficial ownership of securities- Davie Paul JonathanSEC · 2026/11/13
-
Company notice
Schrodinger | 144: Notice of proposed sale of securities pursuant to Rule 144SEC · 2026/11/13
-
Earnings Preview: Schrodinger to Report Financial Results Post-market on November 04Market Newswire · 2026/10/30
-
Rating change
UBS Initiates Schrodinger(SDGR.US) With Hold Rating, Announces Target Price $19Market Newswire · 2026/8/14
-
Company notice
Schrodinger | 144: Notice of proposed sale of securities pursuant to Rule 144SEC · 2026/9/18
-
Rating change
Analysts' Opinions Are Mixed on These Healthcare Stocks: Caribou Biosciences (CRBU), Bristol-Myers Squibb (BMY) and Schrodinger (SDGR)TipRanks · 2026/8/14
-
Rating change
BMO Capital Maintains Schrodinger(SDGR.US) With Buy Rating, Maintains Target Price $24Market Newswire · 2026/8/18
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Schrodinger discussion 0 comments